Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other financing activities (2019 - 2025)

Historic Other financing activities for Bioadaptives (BDPT) over the last 6 years, with Q2 2025 value amounting to $115000.0.

  • Bioadaptives' Other financing activities changed N/A to $115000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$70833.0, marking a year-over-year change of. This contributed to the annual value of -$2500.0 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Bioadaptives' Other financing activities is $115000.0.
  • Over the past 5 years, Bioadaptives' Other financing activities peaked at $115000.0 during Q2 2025, and registered a low of -$167500.0 during Q4 2023.
  • In the last 4 years, Bioadaptives' Other financing activities had a median value of $10000.0 in 2022 and averaged $833.4.
  • As far as peak fluctuations go, Bioadaptives' Other financing activities tumbled by 302.91% in 2021, and later tumbled by 8666.67% in 2022.
  • Over the past 4 years, Bioadaptives' Other financing activities (Quarter) stood at -$28333.0 in 2021, then skyrocketed by 135.29% to $10000.0 in 2022, then plummeted by 1775.0% to -$167500.0 in 2023, then skyrocketed by 168.66% to $115000.0 in 2025.
  • Its Other financing activities stands at $115000.0 for Q2 2025, versus -$167500.0 for Q4 2023 and $10000.0 for Q1 2022.